nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP1A2—Imiquimod—skin cancer	0.152	0.211	CbGbCtD
Aminophylline—CYP2E1—Dacarbazine—skin cancer	0.11	0.153	CbGbCtD
Aminophylline—CYP1A2—Vemurafenib—skin cancer	0.0831	0.116	CbGbCtD
Aminophylline—CYP3A4—Temozolomide—skin cancer	0.0795	0.111	CbGbCtD
Aminophylline—CYP3A4—Imiquimod—skin cancer	0.0795	0.111	CbGbCtD
Aminophylline—CYP1A2—Dacarbazine—skin cancer	0.0637	0.0887	CbGbCtD
Aminophylline—CYP3A4—Vismodegib—skin cancer	0.0551	0.0767	CbGbCtD
Aminophylline—CYP3A4—Vemurafenib—skin cancer	0.0436	0.0606	CbGbCtD
Aminophylline—CYP1A2—Fluorouracil—skin cancer	0.0374	0.052	CbGbCtD
Aminophylline—CYP3A4—Docetaxel—skin cancer	0.0149	0.0208	CbGbCtD
Aminophylline—PDE3A—penis—skin cancer	0.0121	0.198	CbGeAlD
Aminophylline—Status epilepticus—Temozolomide—skin cancer	0.00583	0.0392	CcSEcCtD
Aminophylline—ADORA1—nerve—skin cancer	0.00543	0.0886	CbGeAlD
Aminophylline—HDAC2—hair follicle—skin cancer	0.00449	0.0733	CbGeAlD
Aminophylline—ADORA2B—nipple—skin cancer	0.00429	0.07	CbGeAlD
Aminophylline—Supraventricular tachycardia—Imiquimod—skin cancer	0.0035	0.0235	CcSEcCtD
Aminophylline—HDAC2—neck—skin cancer	0.00301	0.0492	CbGeAlD
Aminophylline—Abdominal pain upper—Vismodegib—skin cancer	0.00288	0.0194	CcSEcCtD
Aminophylline—Hypokalaemia—Vismodegib—skin cancer	0.00287	0.0193	CcSEcCtD
Aminophylline—Gastrooesophageal reflux disease—Imiquimod—skin cancer	0.00254	0.0171	CcSEcCtD
Aminophylline—ADORA2B—mammalian vulva—skin cancer	0.0025	0.0409	CbGeAlD
Aminophylline—Sinus tachycardia—Docetaxel—skin cancer	0.00227	0.0152	CcSEcCtD
Aminophylline—Skin exfoliation—Imiquimod—skin cancer	0.00219	0.0147	CcSEcCtD
Aminophylline—HDAC2—connective tissue—skin cancer	0.00216	0.0352	CbGeAlD
Aminophylline—Atrial fibrillation—Vemurafenib—skin cancer	0.00206	0.0138	CcSEcCtD
Aminophylline—HDAC2—epithelium—skin cancer	0.00205	0.0334	CbGeAlD
Aminophylline—HDAC2—skin of body—skin cancer	0.00195	0.0318	CbGeAlD
Aminophylline—Alopecia—Vismodegib—skin cancer	0.00193	0.013	CcSEcCtD
Aminophylline—Extravasation—Bleomycin—skin cancer	0.00187	0.0125	CcSEcCtD
Aminophylline—ADORA2A—lymphoid tissue—skin cancer	0.00185	0.0302	CbGeAlD
Aminophylline—Heartburn—Fluorouracil—skin cancer	0.00184	0.0124	CcSEcCtD
Aminophylline—ADORA2B—head—skin cancer	0.00179	0.0293	CbGeAlD
Aminophylline—ADORA2A—female reproductive system—skin cancer	0.00178	0.0291	CbGeAlD
Aminophylline—Dermatitis exfoliative—Imiquimod—skin cancer	0.00176	0.0119	CcSEcCtD
Aminophylline—Atrial fibrillation—Imiquimod—skin cancer	0.00176	0.0118	CcSEcCtD
Aminophylline—Extravasation—Dactinomycin—skin cancer	0.00174	0.0117	CcSEcCtD
Aminophylline—Irritability—Imiquimod—skin cancer	0.00159	0.0107	CcSEcCtD
Aminophylline—Urinary retention—Imiquimod—skin cancer	0.00158	0.0106	CcSEcCtD
Aminophylline—PDE3A—female reproductive system—skin cancer	0.00158	0.0258	CbGeAlD
Aminophylline—HDAC2—lymphoid tissue—skin cancer	0.00158	0.0258	CbGeAlD
Aminophylline—Skin exfoliation—Bleomycin—skin cancer	0.00155	0.0105	CcSEcCtD
Aminophylline—ADORA1—female reproductive system—skin cancer	0.00154	0.0252	CbGeAlD
Aminophylline—HDAC2—female reproductive system—skin cancer	0.00152	0.0248	CbGeAlD
Aminophylline—Nervous system disorder—Vismodegib—skin cancer	0.00152	0.0102	CcSEcCtD
Aminophylline—ADORA2A—head—skin cancer	0.00149	0.0243	CbGeAlD
Aminophylline—Extravasation—Fluorouracil—skin cancer	0.00145	0.00975	CcSEcCtD
Aminophylline—CYP1A2—nipple—skin cancer	0.0014	0.0228	CbGeAlD
Aminophylline—Supraventricular tachycardia—Docetaxel—skin cancer	0.00139	0.00937	CcSEcCtD
Aminophylline—Phlebitis—Bleomycin—skin cancer	0.00137	0.00922	CcSEcCtD
Aminophylline—Dyspepsia—Vismodegib—skin cancer	0.00137	0.00919	CcSEcCtD
Aminophylline—Decreased appetite—Vismodegib—skin cancer	0.00135	0.00907	CcSEcCtD
Aminophylline—Heartburn—Docetaxel—skin cancer	0.00133	0.00892	CcSEcCtD
Aminophylline—Disorientation—Bleomycin—skin cancer	0.00132	0.00888	CcSEcCtD
Aminophylline—Skin exfoliation—Temozolomide—skin cancer	0.00131	0.00882	CcSEcCtD
Aminophylline—ADORA1—head—skin cancer	0.00129	0.021	CbGeAlD
Aminophylline—Phlebitis—Dactinomycin—skin cancer	0.00128	0.0086	CcSEcCtD
Aminophylline—HDAC2—head—skin cancer	0.00127	0.0208	CbGeAlD
Aminophylline—Gastrointestinal pain—Vismodegib—skin cancer	0.00127	0.00853	CcSEcCtD
Aminophylline—Dermatitis contact—Fluorouracil—skin cancer	0.00125	0.00841	CcSEcCtD
Aminophylline—Abdominal pain—Vismodegib—skin cancer	0.00123	0.00825	CcSEcCtD
Aminophylline—Alopecia—Vemurafenib—skin cancer	0.00119	0.00802	CcSEcCtD
Aminophylline—Coma—Fluorouracil—skin cancer	0.00116	0.00777	CcSEcCtD
Aminophylline—PDE4A—lymph node—skin cancer	0.00112	0.0183	CbGeAlD
Aminophylline—Pruritus—Vismodegib—skin cancer	0.0011	0.00738	CcSEcCtD
Aminophylline—Flushing—Imiquimod—skin cancer	0.00107	0.00718	CcSEcCtD
Aminophylline—Diarrhoea—Vismodegib—skin cancer	0.00106	0.00714	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Temozolomide—skin cancer	0.00106	0.0071	CcSEcCtD
Aminophylline—Extravasation—Docetaxel—skin cancer	0.00105	0.00704	CcSEcCtD
Aminophylline—Arrhythmia—Imiquimod—skin cancer	0.00103	0.00691	CcSEcCtD
Aminophylline—Disorientation—Fluorouracil—skin cancer	0.00103	0.0069	CcSEcCtD
Aminophylline—Alopecia—Imiquimod—skin cancer	0.00102	0.00684	CcSEcCtD
Aminophylline—Vomiting—Vismodegib—skin cancer	0.000986	0.00663	CcSEcCtD
Aminophylline—Rash—Vismodegib—skin cancer	0.000978	0.00658	CcSEcCtD
Aminophylline—Dermatitis—Vismodegib—skin cancer	0.000977	0.00657	CcSEcCtD
Aminophylline—Anaphylactic shock—Vemurafenib—skin cancer	0.000959	0.00645	CcSEcCtD
Aminophylline—Infection—Vemurafenib—skin cancer	0.000952	0.0064	CcSEcCtD
Aminophylline—Nervous system disorder—Vemurafenib—skin cancer	0.00094	0.00632	CcSEcCtD
Aminophylline—PDE3A—lymph node—skin cancer	0.000925	0.0151	CbGeAlD
Aminophylline—Nausea—Vismodegib—skin cancer	0.000922	0.0062	CcSEcCtD
Aminophylline—Agitation—Imiquimod—skin cancer	0.00092	0.00619	CcSEcCtD
Aminophylline—Hypokalaemia—Temozolomide—skin cancer	0.000907	0.0061	CcSEcCtD
Aminophylline—ADORA1—lymph node—skin cancer	0.000902	0.0147	CbGeAlD
Aminophylline—Hypotension—Vemurafenib—skin cancer	0.000896	0.00602	CcSEcCtD
Aminophylline—HDAC2—lymph node—skin cancer	0.000891	0.0145	CbGeAlD
Aminophylline—Palpitations—Imiquimod—skin cancer	0.000885	0.00595	CcSEcCtD
Aminophylline—Irritability—Fluorouracil—skin cancer	0.000877	0.00589	CcSEcCtD
Aminophylline—Skin exfoliation—Docetaxel—skin cancer	0.000872	0.00586	CcSEcCtD
Aminophylline—Haematuria—Bleomycin—skin cancer	0.000868	0.00584	CcSEcCtD
Aminophylline—Convulsion—Imiquimod—skin cancer	0.000868	0.00584	CcSEcCtD
Aminophylline—Anxiety—Imiquimod—skin cancer	0.00085	0.00572	CcSEcCtD
Aminophylline—Decreased appetite—Vemurafenib—skin cancer	0.000833	0.0056	CcSEcCtD
Aminophylline—Lightheadedness—Docetaxel—skin cancer	0.000817	0.00549	CcSEcCtD
Aminophylline—Infection—Imiquimod—skin cancer	0.000812	0.00546	CcSEcCtD
Aminophylline—Shock—Imiquimod—skin cancer	0.000804	0.00541	CcSEcCtD
Aminophylline—Nervous system disorder—Imiquimod—skin cancer	0.000802	0.00539	CcSEcCtD
Aminophylline—Tachycardia—Imiquimod—skin cancer	0.000798	0.00537	CcSEcCtD
Aminophylline—Anorexia—Imiquimod—skin cancer	0.000779	0.00524	CcSEcCtD
Aminophylline—Hyperglycaemia—Temozolomide—skin cancer	0.000777	0.00523	CcSEcCtD
Aminophylline—Phlebitis—Docetaxel—skin cancer	0.000769	0.00517	CcSEcCtD
Aminophylline—Flushing—Bleomycin—skin cancer	0.000759	0.0051	CcSEcCtD
Aminophylline—Body temperature increased—Vemurafenib—skin cancer	0.000758	0.0051	CcSEcCtD
Aminophylline—Insomnia—Imiquimod—skin cancer	0.000739	0.00497	CcSEcCtD
Aminophylline—Alopecia—Bleomycin—skin cancer	0.000722	0.00486	CcSEcCtD
Aminophylline—Dyspepsia—Imiquimod—skin cancer	0.00072	0.00484	CcSEcCtD
Aminophylline—Decreased appetite—Imiquimod—skin cancer	0.000711	0.00478	CcSEcCtD
Aminophylline—Flushing—Dactinomycin—skin cancer	0.000708	0.00476	CcSEcCtD
Aminophylline—Hypersensitivity—Vemurafenib—skin cancer	0.000706	0.00475	CcSEcCtD
Aminophylline—Atrial fibrillation—Docetaxel—skin cancer	0.000699	0.0047	CcSEcCtD
Aminophylline—Pruritus—Vemurafenib—skin cancer	0.000678	0.00456	CcSEcCtD
Aminophylline—Alopecia—Dactinomycin—skin cancer	0.000674	0.00453	CcSEcCtD
Aminophylline—Gastrointestinal pain—Imiquimod—skin cancer	0.000668	0.0045	CcSEcCtD
Aminophylline—Diarrhoea—Vemurafenib—skin cancer	0.000656	0.00441	CcSEcCtD
Aminophylline—CYP2E1—lymphoid tissue—skin cancer	0.000653	0.0107	CbGeAlD
Aminophylline—Urticaria—Imiquimod—skin cancer	0.000649	0.00437	CcSEcCtD
Aminophylline—Body temperature increased—Imiquimod—skin cancer	0.000646	0.00435	CcSEcCtD
Aminophylline—Abdominal pain—Imiquimod—skin cancer	0.000646	0.00435	CcSEcCtD
Aminophylline—Flushing—Temozolomide—skin cancer	0.00064	0.0043	CcSEcCtD
Aminophylline—Dizziness—Vemurafenib—skin cancer	0.000634	0.00426	CcSEcCtD
Aminophylline—CYP2E1—female reproductive system—skin cancer	0.00063	0.0103	CbGeAlD
Aminophylline—Vomiting—Vemurafenib—skin cancer	0.000609	0.0041	CcSEcCtD
Aminophylline—Alopecia—Temozolomide—skin cancer	0.000609	0.0041	CcSEcCtD
Aminophylline—Abdominal pain upper—Docetaxel—skin cancer	0.000605	0.00407	CcSEcCtD
Aminophylline—Rash—Vemurafenib—skin cancer	0.000604	0.00406	CcSEcCtD
Aminophylline—Dermatitis—Vemurafenib—skin cancer	0.000604	0.00406	CcSEcCtD
Aminophylline—Hypersensitivity—Imiquimod—skin cancer	0.000602	0.00405	CcSEcCtD
Aminophylline—Headache—Vemurafenib—skin cancer	0.0006	0.00404	CcSEcCtD
Aminophylline—Anaphylactic shock—Bleomycin—skin cancer	0.000581	0.00391	CcSEcCtD
Aminophylline—Pruritus—Imiquimod—skin cancer	0.000578	0.00389	CcSEcCtD
Aminophylline—Infection—Bleomycin—skin cancer	0.000577	0.00388	CcSEcCtD
Aminophylline—Nausea—Vemurafenib—skin cancer	0.000569	0.00383	CcSEcCtD
Aminophylline—Arrhythmia—Fluorouracil—skin cancer	0.000568	0.00382	CcSEcCtD
Aminophylline—Tremor—Temozolomide—skin cancer	0.000562	0.00378	CcSEcCtD
Aminophylline—Alopecia—Fluorouracil—skin cancer	0.000561	0.00378	CcSEcCtD
Aminophylline—Diarrhoea—Imiquimod—skin cancer	0.000559	0.00376	CcSEcCtD
Aminophylline—Anorexia—Bleomycin—skin cancer	0.000554	0.00372	CcSEcCtD
Aminophylline—Agitation—Temozolomide—skin cancer	0.000552	0.00371	CcSEcCtD
Aminophylline—Hypotension—Bleomycin—skin cancer	0.000543	0.00365	CcSEcCtD
Aminophylline—Dizziness—Imiquimod—skin cancer	0.000541	0.00364	CcSEcCtD
Aminophylline—Infection—Dactinomycin—skin cancer	0.000538	0.00362	CcSEcCtD
Aminophylline—Palpitations—Temozolomide—skin cancer	0.00053	0.00357	CcSEcCtD
Aminophylline—CYP2E1—head—skin cancer	0.000526	0.00859	CbGeAlD
Aminophylline—Convulsion—Temozolomide—skin cancer	0.00052	0.0035	CcSEcCtD
Aminophylline—Vomiting—Imiquimod—skin cancer	0.00052	0.0035	CcSEcCtD
Aminophylline—Anorexia—Dactinomycin—skin cancer	0.000516	0.00347	CcSEcCtD
Aminophylline—Rash—Imiquimod—skin cancer	0.000515	0.00347	CcSEcCtD
Aminophylline—Dermatitis—Imiquimod—skin cancer	0.000515	0.00346	CcSEcCtD
Aminophylline—Headache—Imiquimod—skin cancer	0.000512	0.00344	CcSEcCtD
Aminophylline—Anxiety—Temozolomide—skin cancer	0.000509	0.00342	CcSEcCtD
Aminophylline—CYP3A4—female reproductive system—skin cancer	0.000507	0.00827	CbGeAlD
Aminophylline—Decreased appetite—Bleomycin—skin cancer	0.000505	0.0034	CcSEcCtD
Aminophylline—Anaphylactic shock—Temozolomide—skin cancer	0.00049	0.00329	CcSEcCtD
Aminophylline—Infection—Temozolomide—skin cancer	0.000487	0.00327	CcSEcCtD
Aminophylline—Nausea—Imiquimod—skin cancer	0.000486	0.00327	CcSEcCtD
Aminophylline—Nervous system disorder—Temozolomide—skin cancer	0.00048	0.00323	CcSEcCtD
Aminophylline—Convulsion—Fluorouracil—skin cancer	0.000479	0.00322	CcSEcCtD
Aminophylline—Decreased appetite—Dactinomycin—skin cancer	0.000471	0.00317	CcSEcCtD
Aminophylline—Anorexia—Temozolomide—skin cancer	0.000467	0.00314	CcSEcCtD
Aminophylline—Urticaria—Bleomycin—skin cancer	0.000461	0.0031	CcSEcCtD
Aminophylline—Body temperature increased—Bleomycin—skin cancer	0.000459	0.00309	CcSEcCtD
Aminophylline—Anaphylactic shock—Fluorouracil—skin cancer	0.000451	0.00304	CcSEcCtD
Aminophylline—Infection—Fluorouracil—skin cancer	0.000448	0.00302	CcSEcCtD
Aminophylline—Insomnia—Temozolomide—skin cancer	0.000443	0.00298	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dactinomycin—skin cancer	0.000443	0.00298	CcSEcCtD
Aminophylline—Nervous system disorder—Fluorouracil—skin cancer	0.000443	0.00298	CcSEcCtD
Aminophylline—Tachycardia—Fluorouracil—skin cancer	0.000441	0.00296	CcSEcCtD
Aminophylline—Dyspepsia—Temozolomide—skin cancer	0.000431	0.0029	CcSEcCtD
Aminophylline—Anorexia—Fluorouracil—skin cancer	0.00043	0.00289	CcSEcCtD
Aminophylline—Body temperature increased—Dactinomycin—skin cancer	0.000428	0.00288	CcSEcCtD
Aminophylline—Abdominal pain—Dactinomycin—skin cancer	0.000428	0.00288	CcSEcCtD
Aminophylline—Hypersensitivity—Bleomycin—skin cancer	0.000428	0.00288	CcSEcCtD
Aminophylline—Decreased appetite—Temozolomide—skin cancer	0.000426	0.00286	CcSEcCtD
Aminophylline—Flushing—Docetaxel—skin cancer	0.000426	0.00286	CcSEcCtD
Aminophylline—Hypotension—Fluorouracil—skin cancer	0.000422	0.00284	CcSEcCtD
Aminophylline—Pruritus—Bleomycin—skin cancer	0.000411	0.00276	CcSEcCtD
Aminophylline—Arrhythmia—Docetaxel—skin cancer	0.00041	0.00275	CcSEcCtD
Aminophylline—Insomnia—Fluorouracil—skin cancer	0.000408	0.00275	CcSEcCtD
Aminophylline—Alopecia—Docetaxel—skin cancer	0.000405	0.00273	CcSEcCtD
Aminophylline—Gastrointestinal pain—Temozolomide—skin cancer	0.000401	0.00269	CcSEcCtD
Aminophylline—Hypersensitivity—Dactinomycin—skin cancer	0.000399	0.00268	CcSEcCtD
Aminophylline—Dyspepsia—Fluorouracil—skin cancer	0.000397	0.00267	CcSEcCtD
Aminophylline—Decreased appetite—Fluorouracil—skin cancer	0.000392	0.00264	CcSEcCtD
Aminophylline—Urticaria—Temozolomide—skin cancer	0.000389	0.00262	CcSEcCtD
Aminophylline—Abdominal pain—Temozolomide—skin cancer	0.000387	0.0026	CcSEcCtD
Aminophylline—Body temperature increased—Temozolomide—skin cancer	0.000387	0.0026	CcSEcCtD
Aminophylline—Diarrhoea—Dactinomycin—skin cancer	0.000371	0.00249	CcSEcCtD
Aminophylline—Vomiting—Bleomycin—skin cancer	0.000369	0.00248	CcSEcCtD
Aminophylline—Rash—Bleomycin—skin cancer	0.000366	0.00246	CcSEcCtD
Aminophylline—Dermatitis—Bleomycin—skin cancer	0.000366	0.00246	CcSEcCtD
Aminophylline—Hypersensitivity—Temozolomide—skin cancer	0.000361	0.00243	CcSEcCtD
Aminophylline—Urticaria—Fluorouracil—skin cancer	0.000359	0.00241	CcSEcCtD
Aminophylline—Body temperature increased—Fluorouracil—skin cancer	0.000357	0.0024	CcSEcCtD
Aminophylline—Palpitations—Docetaxel—skin cancer	0.000353	0.00237	CcSEcCtD
Aminophylline—Pruritus—Temozolomide—skin cancer	0.000347	0.00233	CcSEcCtD
Aminophylline—Convulsion—Docetaxel—skin cancer	0.000346	0.00233	CcSEcCtD
Aminophylline—Nausea—Bleomycin—skin cancer	0.000345	0.00232	CcSEcCtD
Aminophylline—Vomiting—Dactinomycin—skin cancer	0.000344	0.00232	CcSEcCtD
Aminophylline—Rash—Dactinomycin—skin cancer	0.000341	0.0023	CcSEcCtD
Aminophylline—Diarrhoea—Temozolomide—skin cancer	0.000335	0.00225	CcSEcCtD
Aminophylline—Hypersensitivity—Fluorouracil—skin cancer	0.000333	0.00224	CcSEcCtD
Aminophylline—Anaphylactic shock—Docetaxel—skin cancer	0.000326	0.00219	CcSEcCtD
Aminophylline—Dizziness—Temozolomide—skin cancer	0.000324	0.00218	CcSEcCtD
Aminophylline—Infection—Docetaxel—skin cancer	0.000324	0.00218	CcSEcCtD
Aminophylline—Nausea—Dactinomycin—skin cancer	0.000322	0.00216	CcSEcCtD
Aminophylline—Shock—Docetaxel—skin cancer	0.000321	0.00216	CcSEcCtD
Aminophylline—Nervous system disorder—Docetaxel—skin cancer	0.000319	0.00215	CcSEcCtD
Aminophylline—Pruritus—Fluorouracil—skin cancer	0.000319	0.00215	CcSEcCtD
Aminophylline—Tachycardia—Docetaxel—skin cancer	0.000318	0.00214	CcSEcCtD
Aminophylline—Vomiting—Temozolomide—skin cancer	0.000311	0.00209	CcSEcCtD
Aminophylline—Anorexia—Docetaxel—skin cancer	0.000311	0.00209	CcSEcCtD
Aminophylline—Rash—Temozolomide—skin cancer	0.000309	0.00208	CcSEcCtD
Aminophylline—Diarrhoea—Fluorouracil—skin cancer	0.000309	0.00208	CcSEcCtD
Aminophylline—Dermatitis—Temozolomide—skin cancer	0.000309	0.00208	CcSEcCtD
Aminophylline—Headache—Temozolomide—skin cancer	0.000307	0.00206	CcSEcCtD
Aminophylline—Hypotension—Docetaxel—skin cancer	0.000304	0.00205	CcSEcCtD
Aminophylline—Dizziness—Fluorouracil—skin cancer	0.000298	0.00201	CcSEcCtD
Aminophylline—Insomnia—Docetaxel—skin cancer	0.000295	0.00198	CcSEcCtD
Aminophylline—Nausea—Temozolomide—skin cancer	0.000291	0.00196	CcSEcCtD
Aminophylline—Vomiting—Fluorouracil—skin cancer	0.000287	0.00193	CcSEcCtD
Aminophylline—Dyspepsia—Docetaxel—skin cancer	0.000287	0.00193	CcSEcCtD
Aminophylline—Rash—Fluorouracil—skin cancer	0.000285	0.00191	CcSEcCtD
Aminophylline—Dermatitis—Fluorouracil—skin cancer	0.000284	0.00191	CcSEcCtD
Aminophylline—Decreased appetite—Docetaxel—skin cancer	0.000283	0.0019	CcSEcCtD
Aminophylline—Headache—Fluorouracil—skin cancer	0.000283	0.0019	CcSEcCtD
Aminophylline—Nausea—Fluorouracil—skin cancer	0.000268	0.0018	CcSEcCtD
Aminophylline—Gastrointestinal pain—Docetaxel—skin cancer	0.000266	0.00179	CcSEcCtD
Aminophylline—Abdominal pain—Docetaxel—skin cancer	0.000258	0.00173	CcSEcCtD
Aminophylline—Body temperature increased—Docetaxel—skin cancer	0.000258	0.00173	CcSEcCtD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00025	0.00351	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—MC1R—skin cancer	0.000249	0.00349	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RHOU—skin cancer	0.000248	0.00349	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—PTGER4—skin cancer	0.000246	0.00346	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—CDK4—skin cancer	0.000243	0.00342	CbGpPWpGaD
Aminophylline—Hypersensitivity—Docetaxel—skin cancer	0.00024	0.00161	CcSEcCtD
Aminophylline—ADORA2A—Signaling by NGF—FOXO4—skin cancer	0.000237	0.00333	CbGpPWpGaD
Aminophylline—ADORA2B—C-MYB transcription factor network—HRAS—skin cancer	0.000234	0.00329	CbGpPWpGaD
Aminophylline—Pruritus—Docetaxel—skin cancer	0.00023	0.00155	CcSEcCtD
Aminophylline—PDE4A—G Protein Signaling Pathways—KRAS—skin cancer	0.00023	0.00324	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—MC1R—skin cancer	0.000226	0.00317	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—MC1R—skin cancer	0.000226	0.00317	CbGpPWpGaD
Aminophylline—Diarrhoea—Docetaxel—skin cancer	0.000223	0.0015	CcSEcCtD
Aminophylline—PDE3A—GPCR downstream signaling—MC1R—skin cancer	0.00022	0.00309	CbGpPWpGaD
Aminophylline—HDAC2—Transcription—ERCC2—skin cancer	0.000216	0.00303	CbGpPWpGaD
Aminophylline—Dizziness—Docetaxel—skin cancer	0.000215	0.00145	CcSEcCtD
Aminophylline—ADORA1—GPCR downstream signaling—MC1R—skin cancer	0.000212	0.00297	CbGpPWpGaD
Aminophylline—Vomiting—Docetaxel—skin cancer	0.000207	0.00139	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—SHH—skin cancer	0.000206	0.00289	CbGpPWpGaD
Aminophylline—Rash—Docetaxel—skin cancer	0.000205	0.00138	CcSEcCtD
Aminophylline—PDE4A—Signaling by GPCR—MC1R—skin cancer	0.000205	0.00288	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PTCH2—skin cancer	0.000205	0.00288	CbGpPWpGaD
Aminophylline—Dermatitis—Docetaxel—skin cancer	0.000205	0.00138	CcSEcCtD
Aminophylline—Headache—Docetaxel—skin cancer	0.000204	0.00137	CcSEcCtD
Aminophylline—HDAC2—Circadian rythm related genes—CDK4—skin cancer	0.000202	0.00284	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—MC1R—skin cancer	0.0002	0.0028	CbGpPWpGaD
Aminophylline—PDE4A—G Protein Signaling Pathways—HRAS—skin cancer	0.000196	0.00275	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—SMO—skin cancer	0.000195	0.00274	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—PTCH1—skin cancer	0.000195	0.00274	CbGpPWpGaD
Aminophylline—Nausea—Docetaxel—skin cancer	0.000194	0.0013	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—MC1R—skin cancer	0.000192	0.0027	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—PTGER4—skin cancer	0.00019	0.00267	CbGpPWpGaD
Aminophylline—HDAC2—Chromatin modifying enzymes—CDK4—skin cancer	0.00019	0.00267	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—CDK4—skin cancer	0.000188	0.00264	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTCH2—skin cancer	0.000185	0.00259	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—skin cancer	0.000176	0.00247	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTCH2—skin cancer	0.000168	0.00235	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—PTGER4—skin cancer	0.000164	0.0023	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—MC1R—skin cancer	0.000163	0.00229	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTCH2—skin cancer	0.000163	0.00229	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—skin cancer	0.000163	0.00229	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.000161	0.00226	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—SHH—skin cancer	0.000161	0.00226	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTCH2—skin cancer	0.000157	0.0022	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PTCH1—skin cancer	0.000153	0.00214	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—SMO—skin cancer	0.000153	0.00214	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PTGER4—skin cancer	0.000149	0.00209	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—PTGER4—skin cancer	0.000149	0.00209	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—MC1R—skin cancer	0.000148	0.00208	CbGpPWpGaD
Aminophylline—HDAC2—Cell Cycle—TP53—skin cancer	0.000148	0.00208	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—SHH—skin cancer	0.000146	0.00205	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—PTGER4—skin cancer	0.000145	0.00203	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—SHH—skin cancer	0.000142	0.002	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CSPG4—skin cancer	0.000141	0.00198	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NOTCH—TP53—skin cancer	0.00014	0.00197	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—GLI2—skin cancer	0.00014	0.00196	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—PTGER4—skin cancer	0.000139	0.00195	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PTCH1—skin cancer	0.000139	0.00195	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—SMO—skin cancer	0.000139	0.00195	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—SHH—skin cancer	0.000137	0.00192	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PTGER4—skin cancer	0.000135	0.00189	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—BRAF—skin cancer	0.000135	0.00189	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—SMO—skin cancer	0.000135	0.00189	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PTCH1—skin cancer	0.000135	0.00189	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MC1R—skin cancer	0.000134	0.00187	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—GLI1—skin cancer	0.000132	0.00185	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PTGER4—skin cancer	0.000131	0.00184	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTCH2—skin cancer	0.00013	0.00183	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PTCH1—skin cancer	0.00013	0.00182	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—SMO—skin cancer	0.00013	0.00182	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—GLI2—skin cancer	0.000127	0.00178	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PTGER4—skin cancer	0.000126	0.00177	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—BRAF—skin cancer	0.000125	0.00176	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SUFU—skin cancer	0.000125	0.00175	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—GLI2—skin cancer	0.000124	0.00174	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000121	0.0017	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MC1R—skin cancer	0.000121	0.0017	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTCH2—skin cancer	0.000121	0.0017	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—GLI1—skin cancer	0.00012	0.00168	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—GLI2—skin cancer	0.000119	0.00167	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MC1R—skin cancer	0.000118	0.00166	CbGpPWpGaD
Aminophylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—skin cancer	0.000118	0.00165	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—GLI1—skin cancer	0.000116	0.00163	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—TP53—skin cancer	0.000115	0.00161	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MC1R—skin cancer	0.000114	0.00159	CbGpPWpGaD
Aminophylline—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	0.000113	0.00159	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SUFU—skin cancer	0.000113	0.00159	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—GLI1—skin cancer	0.000112	0.00157	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SUFU—skin cancer	0.00011	0.00155	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PTGER4—skin cancer	0.000107	0.00151	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SUFU—skin cancer	0.000106	0.00149	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—SHH—skin cancer	0.000106	0.00148	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—TP53—skin cancer	0.000104	0.00145	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000102	0.00144	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PTCH1—skin cancer	0.0001	0.00141	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—SMO—skin cancer	0.0001	0.00141	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GLI2—skin cancer	9.88e-05	0.00139	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PTGER4—skin cancer	9.76e-05	0.00137	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SHH—skin cancer	9.6e-05	0.00135	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ENO2—skin cancer	9.6e-05	0.00135	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SHH—skin cancer	9.52e-05	0.00134	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—IL6—skin cancer	9.48e-05	0.00133	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—RASA1—skin cancer	9.46e-05	0.00133	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	9.44e-05	0.00132	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MC1R—skin cancer	9.43e-05	0.00132	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GLI1—skin cancer	9.29e-05	0.0013	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GLI2—skin cancer	9.19e-05	0.00129	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTCH1—skin cancer	9.02e-05	0.00127	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SMO—skin cancer	9.02e-05	0.00127	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	8.82e-05	0.00124	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SUFU—skin cancer	8.81e-05	0.00124	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTGER4—skin cancer	8.78e-05	0.00123	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MC1R—skin cancer	8.77e-05	0.00123	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SHH—skin cancer	8.64e-05	0.00121	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GLI1—skin cancer	8.64e-05	0.00121	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—TP53—skin cancer	8.6e-05	0.00121	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—RASA1—skin cancer	8.59e-05	0.00121	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.5e-05	0.00119	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—NRAS—skin cancer	8.48e-05	0.00119	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SHH—skin cancer	8.4e-05	0.00118	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—RASA1—skin cancer	8.35e-05	0.00117	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SUFU—skin cancer	8.19e-05	0.00115	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SMO—skin cancer	8.19e-05	0.00115	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTCH1—skin cancer	8.19e-05	0.00115	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	8.12e-05	0.00114	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SHH—skin cancer	8.09e-05	0.00114	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RASA1—skin cancer	8.04e-05	0.00113	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—TP53—skin cancer	7.99e-05	0.00112	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTGER4—skin cancer	7.97e-05	0.00112	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SMO—skin cancer	7.97e-05	0.00112	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTCH1—skin cancer	7.97e-05	0.00112	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—NRAS—skin cancer	7.88e-05	0.00111	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—IL6—skin cancer	7.87e-05	0.0011	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FOXO4—skin cancer	7.82e-05	0.0011	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FOXO4—skin cancer	7.76e-05	0.00109	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTGER4—skin cancer	7.76e-05	0.00109	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTCH1—skin cancer	7.67e-05	0.00108	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SMO—skin cancer	7.67e-05	0.00108	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	7.5e-05	0.00105	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTGER4—skin cancer	7.47e-05	0.00105	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—IL6—skin cancer	7.32e-05	0.00103	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—KRAS—skin cancer	7.3e-05	0.00102	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	7.18e-05	0.00101	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FOXO4—skin cancer	7.04e-05	0.000989	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	6.9e-05	0.000969	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FOXO4—skin cancer	6.85e-05	0.000962	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KRAS—skin cancer	6.78e-05	0.000952	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SHH—skin cancer	6.72e-05	0.000943	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—NRAS—skin cancer	6.72e-05	0.000943	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RASA1—skin cancer	6.68e-05	0.000937	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FOXO4—skin cancer	6.6e-05	0.000926	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTCH1—skin cancer	6.37e-05	0.000894	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SMO—skin cancer	6.37e-05	0.000894	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PLIN2—skin cancer	6.29e-05	0.000884	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SHH—skin cancer	6.25e-05	0.000877	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RASA1—skin cancer	6.21e-05	0.000871	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—HRAS—skin cancer	6.2e-05	0.000871	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTGER4—skin cancer	6.2e-05	0.00087	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—ERCC2—skin cancer	6e-05	0.000843	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—IL6—skin cancer	5.94e-05	0.000833	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SMO—skin cancer	5.92e-05	0.000831	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTCH1—skin cancer	5.92e-05	0.000831	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—KRAS—skin cancer	5.78e-05	0.000812	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—HRAS—skin cancer	5.77e-05	0.000809	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTGER4—skin cancer	5.76e-05	0.000809	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ERCC2—skin cancer	5.57e-05	0.000782	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—IL6—skin cancer	5.52e-05	0.000775	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FOXO4—skin cancer	5.48e-05	0.000769	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—NRAS—skin cancer	5.37e-05	0.000754	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TERT—skin cancer	5.22e-05	0.000733	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TERT—skin cancer	5.18e-05	0.000727	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—skin cancer	5.14e-05	0.000721	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FOXO4—skin cancer	5.09e-05	0.000715	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CSPG4—skin cancer	5.07e-05	0.000712	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—HRAS—skin cancer	4.91e-05	0.00069	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TERT—skin cancer	4.7e-05	0.00066	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—KRAS—skin cancer	4.62e-05	0.000649	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TERT—skin cancer	4.58e-05	0.000642	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TERT—skin cancer	4.41e-05	0.000618	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—NRAS—skin cancer	4.36e-05	0.000613	CbGpPWpGaD
Aminophylline—HDAC2—Disease—BRAF—skin cancer	4.14e-05	0.000581	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—skin cancer	4.11e-05	0.000577	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—BRAF—skin cancer	4.1e-05	0.000576	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—NRAS—skin cancer	3.96e-05	0.000556	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—HRAS—skin cancer	3.93e-05	0.000552	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—NRAS—skin cancer	3.86e-05	0.000541	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PLIN2—skin cancer	3.78e-05	0.000531	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—KRAS—skin cancer	3.76e-05	0.000527	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—BRAF—skin cancer	3.73e-05	0.000523	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—NRAS—skin cancer	3.71e-05	0.000521	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TERT—skin cancer	3.66e-05	0.000514	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—BRAF—skin cancer	3.62e-05	0.000509	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—BRAF—skin cancer	3.49e-05	0.00049	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ENO2—skin cancer	3.45e-05	0.000484	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—KRAS—skin cancer	3.41e-05	0.000479	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TERT—skin cancer	3.4e-05	0.000477	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—skin cancer	3.34e-05	0.000469	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—KRAS—skin cancer	3.32e-05	0.000466	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—KRAS—skin cancer	3.19e-05	0.000448	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—HRAS—skin cancer	3.19e-05	0.000448	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL6—skin cancer	3.06e-05	0.000429	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CSPG4—skin cancer	3.05e-05	0.000428	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PLIN2—skin cancer	2.92e-05	0.00041	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—HRAS—skin cancer	2.9e-05	0.000407	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—BRAF—skin cancer	2.9e-05	0.000407	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—NRAS—skin cancer	2.87e-05	0.000402	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—HRAS—skin cancer	2.82e-05	0.000396	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL6—skin cancer	2.78e-05	0.00039	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—HRAS—skin cancer	2.72e-05	0.000381	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL6—skin cancer	2.7e-05	0.000379	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—BRAF—skin cancer	2.69e-05	0.000378	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NRAS—skin cancer	2.6e-05	0.000365	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—skin cancer	2.6e-05	0.000365	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NRAS—skin cancer	2.58e-05	0.000362	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—skin cancer	2.47e-05	0.000346	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CSPG4—skin cancer	2.35e-05	0.00033	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NRAS—skin cancer	2.34e-05	0.000329	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NRAS—skin cancer	2.28e-05	0.00032	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—skin cancer	2.24e-05	0.000314	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—skin cancer	2.22e-05	0.000312	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NRAS—skin cancer	2.19e-05	0.000308	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—skin cancer	2.1e-05	0.000294	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—skin cancer	2.07e-05	0.000291	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—skin cancer	2.02e-05	0.000283	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—skin cancer	2.01e-05	0.000282	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ERCC2—skin cancer	2e-05	0.000281	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—skin cancer	1.97e-05	0.000277	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—skin cancer	1.96e-05	0.000275	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—skin cancer	1.9e-05	0.000267	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—skin cancer	1.89e-05	0.000265	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—skin cancer	1.89e-05	0.000265	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NRAS—skin cancer	1.82e-05	0.000256	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—skin cancer	1.82e-05	0.000256	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—skin cancer	1.81e-05	0.000253	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—skin cancer	1.79e-05	0.000251	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—skin cancer	1.74e-05	0.000245	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—skin cancer	1.71e-05	0.00024	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NRAS—skin cancer	1.69e-05	0.000238	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—skin cancer	1.68e-05	0.000235	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—skin cancer	1.67e-05	0.000234	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—skin cancer	1.64e-05	0.00023	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.62e-05	0.000228	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—skin cancer	1.6e-05	0.000225	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—skin cancer	1.6e-05	0.000225	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—skin cancer	1.59e-05	0.000224	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—skin cancer	1.57e-05	0.00022	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—skin cancer	1.54e-05	0.000215	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—skin cancer	1.46e-05	0.000205	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—skin cancer	1.39e-05	0.000196	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—skin cancer	1.33e-05	0.000187	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—skin cancer	1.29e-05	0.000182	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—skin cancer	1.27e-05	0.000179	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—skin cancer	1.24e-05	0.000174	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ERCC2—skin cancer	1.2e-05	0.000169	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—skin cancer	1.2e-05	0.000169	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—skin cancer	1.19e-05	0.000166	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ERCC2—skin cancer	9.29e-06	0.00013	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—skin cancer	7.22e-06	0.000101	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—skin cancer	5.57e-06	7.82e-05	CbGpPWpGaD
